The Training Rheum

The Training Rheum 2026 is a concise, virtual training program for advanced practice providers (APPs) new to rheumatology that combines online learning modules and access to an expert-led, recorded training session to educate APPs on comprehensive history and physical examinations for new patients; performing a disease-focused history and physical examination for established patients; formulating an appropriate differential diagnosis; ordering appropriate diagnostic testing and interpreting testing to create treatment plans; recognizing the impact of social determinants of health; discerning skin disease manifestations in diverse populations; and developing the ability to diagnose and manage rheumatic diseases in the rheumatology setting.

We recommend learners complete the activity material prior to watching the expert-led training session.

Target Audience
This activity will be designed for advanced practice providers (APPs) which encompasses both nurse practitioners and physician assistants, fellows in training, and pharmacists who are new to rheumatology.

Learning Objectives
Upon completion of this activity, participants should be able to:

• Be versed in components of a history and physical examination for a new patient, including a detailed musculoskeletal examination, joint assessment, and joint injections
• Be proficient with foundational components of a disease-focused history and physical examination for a follow-up patient, including musculoskeletal examination, joint assessment, and joint injections
• Formulate an appropriate differential diagnosis
• Order appropriate laboratory, radiographic examinations, and other diagnostic testing
• Utilize and integrate results of laboratory, radiographic examinations, and other diagnostic testing into management plans under the supervision/collaboration of a rheumatologist
• Recognize the impact of social determinants of health and health disparities on provision of care and disease self-management when providing healthcare to diverse communities and populations
• Recognize skin manifestations in diverse patient populations/ skin of color
• With appropriate supervision/collaboration, recognize and manage a number of rheumatic diseases in the adult and pediatric rheumatology clinic setting

CE

In support of improving patient care, the American College of Rheumatology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Provider Number: 0003797

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Credits must be claimed by March 24, 2029, at 11:59 PM ET.

Joint Accreditation Statement
This activity was planned by and for the healthcare team, and learners will receive 11.50 Interprofessional Continuing Education credits for learning and change.

CME Designation Statement

The ACR designates this Blended Virtual Learning activity for a maximum of 11.50 AMA PRA Category 1 Credit(s)™.

AAPA Designation Statement

Through joint accreditation, the American College of Rheumatology has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME™ credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.50 AAPA Category 1 CME™ credits. PAs should claim only the credit commensurate with the extent of their participation in the activity.

ACPE Designation Statement

The American College of Rheumatology designates this Blended Virtual Learning activity for a maximum of 11.50 hours of ACPE contact hour(s). Pharmacists and pharmacy technicians should claim only the credit commensurate with the extent of their participation in the activity. Credit will be uploaded to the NABP CPE Monitor® within 60 days after activity completion. Per ACPE rules, ACR does not have access nor the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information (NABP ID and date of birth (MMDD)) to receive credit. The Universal Activity Number for this activity is JA0003797-0000-26-001-H99-P.

All continuing pharmacy education credits must be claimed within 60 days of the Blended Virtual Learning activity you attend. To be sure your CE is accepted inside of ACPE's 60-day window, plan to process your CE before March 24, 2029, at 11:59 PM ET. After the 60-day deadline, ACR will no longer be able to award credit for this activity.

ANCC Designation Statement

The American College of Rheumatology designates this Blended Virtual Learning activity for a maximum of 11.50 ANCC contact hours.

See the ACR’s CE Mission Statement. For more information, download the AMA PRA Booklet.

All participating healthcare professionals, including physicians, nurses, pharmacists, and other medical staff, should claim only the credit commensurate with the extent of their participation in this activity.

   

Instructions to Claim CE/MOC Credit

Credit claiming is available after the activity starts.

See instructions to claim credit on the CE & MOC page.

Certificates
After claiming credit, you can access and print certificates in the ACR Education Center on the My Learning page.

Financial Relationships Disclosures

ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CE activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CE activity.

Nature of Financial Relationships
All individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:

1. Advisor or review panel member
2. Consultant
3. Employee
4. Officer or Board Member
5. Grant/research support
6. Speaker/honoraria includes speakers bureau, symposia, and expert witness
7. Independent contractor
8. Executive role and/or ownership interest
9. Royalties and/or patient beneficiary
10. Intellectual property/patents
11. Stock options or bond holdings in a for-profit corporation or self-directed pension plan
12. Private investigator
13. Expert witness
14. Equity interest
15. Other: specify details

None: Has no relevant financial relationship(s) with ineligible companies to disclose.

All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated.

View The Training Rheum 2026 Financial Relationships Disclosures >

View ACR's ACCME disclosure practices >